Research location
Kochi
India
Advertisement
Research activity in Kochi
IndiaCureCurrent currently publishes aggregate city-level research activity for this location: 50 trials and 58 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Kochi
50 linked trials · page 1 of 1A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFNCT07761117 · 2026-08-24 · 2 site observations
RECRUITING
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes MellitusNCT07784725 · 2026-08-19 · 1 site observation
RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background InsulinNCT07664553 · 2026-07-08 · 1 site observation
RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes MellitusNCT07662109 · 2026-07-06 · 2 site observations
RECRUITING
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseNCT07181109 · 2025-09-22 · 2 site observations
RECRUITING
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseNCT07082738 · 2025-06-27 · 1 site observation
RECRUITING
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the HeartNCT06935370 · 2025-05-20 · 1 site observation
RECRUITING
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled CorticosteroidsNCT06932263 · 2025-03-26 · 1 site observation
RECRUITING
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)NCT06883305 · 2025-03-18 · 1 site observation
RECRUITING
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart FailureNCT06424288 · 2024-06-17 · 1 site observation
RECRUITING
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)NCT06103864 · 2023-11-23 · 1 site observation
RECRUITING
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7NCT04613596 · 2020-12-02 · 1 site observation
RECRUITING
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsNCT00271180 · 1983-01-01 · 1 site observation
RECRUITING
Phase 4 Study to Assess the Safety of Trastuzumab Deruxtecan, in Indian PatientsNCT06429761 · 2025-01-02 · 1 site observation
ACTIVE_NOT_RECRUITING
A Phase IIb Study of AZD5462 in Patients With Chronic Heart FailureNCT06299826 · 2024-06-04 · 1 site observation
COMPLETED
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple SclerosisNCT06141473 · 2023-12-13 · 1 site observation
ACTIVE_NOT_RECRUITING
Prospective Multicentre Phase-IV Clinical Trial of Olaparib in Indian Patients With Ovarian and Metastatic Breast CancerNCT04330040 · 2020-05-25 · 1 site observation
COMPLETED
To Evaluate the Safety and Efficacy of Teriflunomide in Patients With Relapsing Forms of Multiple SclerosisNCT03856619 · 2019-03-27 · 1 site observation
COMPLETED
Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)NCT03775486 · 2018-12-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Twelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo® After Oral Antidiabetic Drug Failure, the Side Effect of Toujeo®, and The Cost.NCT03703869 · 2018-03-06 · 4 site observations
COMPLETED
Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular RiskNCT03315143 · 2017-12-19 · 1 site observation
TERMINATED
A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based ChemotherapyNCT01168973 · 2010-12-01 · 1 site observation
COMPLETED
BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).NCT01131676 · 2010-07-01 · 1 site observation
COMPLETED
Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)NCT01147250 · 2010-06-01 · 1 site observation
COMPLETED
A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes MellitusNCT01042769 · 2010-02-01 · 1 site observation
COMPLETED
A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular DiseaseNCT01018173 · 2010-01-01 · 1 site observation
COMPLETED
CANVAS - CANagliflozin cardioVascular Assessment StudyNCT01032629 · 2009-12-09 · 1 site observation
COMPLETED
24-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin GlargineNCT00975286 · 2009-10-01 · 1 site observation
COMPLETED
Thiazolidinedione Intervention With Vitamin D EvaluationNCT00879970 · 2009-05-01 · 3 site observations
TERMINATED
Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic PatientsNCT00900146 · 2009-04-01 · 1 site observation
TERMINATED
Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on MetforminNCT00814372 · 2008-12-01 · 1 site observation
TERMINATED
Effects of LY2189265 on Glycemic Control in Participants With Type 2 DiabetesNCT00791479 · 2008-12-01 · 1 site observation
COMPLETED
Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)NCT00676338 · 2008-11-01 · 1 site observation
COMPLETED
A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy SubjectsNCT00908778 · 2008-10-01 · 1 site observation
UNKNOWN
A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on MetforminNCT00734474 · 2008-08-01 · 1 site observation
COMPLETED
Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 DiabetesNCT00622284 · 2008-02-01 · 1 site observation
COMPLETED
Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 DiabetesNCT00614120 · 2008-01-01 · 1 site observation
COMPLETED
A Study for Non-Smoker Patients With Nonsquamous Non-Small Cell Lung CancerNCT00550173 · 2007-11-01 · 1 site observation
COMPLETED
Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY)NCT00494013 · 2007-08-01 · 1 site observation
COMPLETED
ANDES-AGI-1067 as a Novel Antidiabetic Agent Evaluation StudyNCT00525577 · 2007-08-01 · 1 site observation
UNKNOWN
Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple SclerosisNCT00451451 · 2007-06-01 · 1 site observation
COMPLETED
Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 DiabetesNCT00437112 · 2007-02-01 · 1 site observation
COMPLETED
Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)NCT00500331 · 2007-01-23 · 1 site observation
COMPLETED
EndoTAG-1 in Triple Receptor Negative Breast Cancer PatientsNCT00448305 · 2007-01-01 · 1 site observation
COMPLETED
Evaluate the Efficacy of Insulin Patients With Type 1 DiabetesNCT00356109 · 2006-08-01 · 1 site observation
COMPLETED
A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard ChemotherapyNCT00338286 · 2006-03-02 · 1 site observation
COMPLETED
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPDNCT00157339 · 2005-08-01 · 1 site observation
COMPLETED
Study of Human Insulin Inhalation Powder in Patients With Type 1 DiabetesNCT00127634 · 2005-07-01 · 1 site observation
COMPLETED
A Randomized Phase 3 Trial of Pemetrexed and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Locally Advanced or Metastatic Non Small Cell Lung CancerNCT00087711 · 2004-07-01 · 1 site observation
COMPLETED
A Study to Assess Capecitabine (Xeloda®) in Patients With Locally Advanced or Metastatic Breast CancerNCT00077857 · 2003-07-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.